Shanghai Hile Bio-tech (603718) — Strategic Asset Allocation Index
Shanghai Hile Bio-tech (603718) has a Strategic Asset Allocation Index of 14.7% as of June 2023. Strategic assets (PP&E of CN¥177.59 Million plus long-term investments of CN¥-) total CN¥177.59 Million, measured against net assets of CN¥1.21 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 603718 equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Shanghai Hile Bio-tech Strategic Asset Allocation Index (2012–2022)
This chart shows how Shanghai Hile Bio-tech's Strategic Asset Allocation Index has evolved across 11 annual periods from 2012 to 2022. As of June 2023, the index stands at 14.7%, representing strategic assets of CN¥177.59 Million against net assets of CN¥1.21 Billion CNY. For live market cap and overall valuation, see Shanghai Hile Bio-tech (603718) market capitalisation.
Annual Strategic Asset Allocation Index for Shanghai Hile Bio-tech (2012–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Shanghai Hile Bio-tech from 2012 to 2022, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Shanghai Hile Bio-tech (603718) net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 19.8% | CN¥219.45 Million | CN¥219.45 Million | CN¥- | CN¥1.11 Billion | ▼ -8.2 pp |
| 2021 | 27.9% | CN¥275.90 Million | CN¥275.90 Million | CN¥- | CN¥987.19 Million | ▼ -17.2 pp |
| 2020 | 45.2% | CN¥434.57 Million | CN¥434.57 Million | CN¥- | CN¥962.20 Million | ▼ -2.8 pp |
| 2019 | 48.0% | CN¥476.05 Million | CN¥476.05 Million | CN¥- | CN¥992.57 Million | ▼ -3.0 pp |
| 2018 | 51.0% | CN¥522.68 Million | CN¥497.91 Million | CN¥24.77 Million | CN¥1.03 Billion | ▼ -2.3 pp |
| 2017 | 53.3% | CN¥572.42 Million | CN¥457.78 Million | CN¥114.64 Million | CN¥1.07 Billion | ▲ +8.3 pp |
| 2016 | 45.0% | CN¥451.99 Million | CN¥441.99 Million | CN¥10.00 Million | CN¥1.01 Billion | ▲ +6.2 pp |
| 2015 | 38.7% | CN¥373.19 Million | CN¥373.19 Million | CN¥- | CN¥963.31 Million | ▼ -6.8 pp |
| 2014 | 45.5% | CN¥254.14 Million | CN¥254.14 Million | CN¥- | CN¥558.50 Million | ▲ +5.4 pp |
| 2013 | 40.1% | CN¥200.92 Million | CN¥200.92 Million | CN¥- | CN¥500.66 Million | ▼ -5.8 pp |
| 2012 | 45.9% | CN¥214.80 Million | CN¥214.80 Million | CN¥- | CN¥467.89 Million | — |